.jpg)
Search
- 2 days ago
- 4 min
ApiJect raises $111 million to transform the fill, finish and delivery of injectable vaccines
ApiJect is developing a truly innovative technology, that could transform the manufacturing and delivery of life-saving injectable drugs.
- May 14
- 7 min
Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS
We continue to push the boundaries of innovation with RADICAVA ORS, an orally administered option allowing patients flexibility...
- May 10
- 3 min
Gerresheimer and Portal partner to treat patients with needle-free drug delivery
the partners aim at transforming the administration of injectable medicines and improving the patient’s experience.
- May 8
- 8 min
Tubulis closes on $63 Million to advance its pipeline of uniquely assembled antibody drug conjugates
Tubulis’ capability of creating antibody-drug conjugates is based on a range of targeting molecules, novel payloads and technology.
- May 7
- 2 min
Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial
Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories
- May 4
- 3 min
Four pharma solution providers launch Norstella to provide faster patient access to therapies
By launching Norstella, we’re taking the next step toward ensuring tha.t all patients have access to the therapies that they need
- Apr 29
- 2 min
InMed seeks patents for cannabinoid analogs
The patent application covers new chemical entities that can be compared to other drugs in order to select candidates for advancement.
- Apr 24
- 4 min
Bayer to join forces with Ginkgo Bioworks to advance Joyn Bio's technology platforms
The transaction will enable Bayer to expand its leading biologicals position.
- Apr 22
- 4 min
Enzyvant to Expand its Regenerative Medicine Manufacturing Capabilities with New Facility
Enzyvant is a commercial-stage biotechnology company with a focus on regenerative medicines for rare diseases.
- Apr 15
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test
“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.
- Apr 13
- 3 min
Surf Bio Wraps up $16 Million Seed Financing to Advance Breakthrough Drug Stabilization Technology
Surf Bio is a preclinical biopharmaceutical company leveraging a novel biotechnology platform to develop enhanced therapeutic solutions,,,
- Apr 12
- 3 min
Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies for mRNA Medicines
Turn Bio is a pre-clinical-stage biopharmaceutical company focused on cellular repair via epigenetic reprogramming of cells.
- Apr 6
- 3 min
Contract development and manufacturing organization BioCina receives a grant to advance RNA vaccines
BioCina has pharmaceutical development and manufacturing experience, augmented with the acquisition of Pfizer’s facilities in Australia
- Mar 26
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform
Globally, liver cancers are the fourth most common cause of cancer-related death and ranked sixth in terms of annual incidence.
- Mar 24
- 3 min
Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic
Sen-Jam and KVK Tech will complete their phase II clinical trials or their oral COVID-19 drug, to have a finished product in 9-12 months.
- Mar 22
- 5 min
Essential medicine public benefit company Phlow announces strategic alliances for R&D
Phlow is an innovative essential medicines impact company that is reimagining the essential medicine supply chain through innovation.
- Mar 21
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics
“Cell therapies have become an essential modality in the oncology therapeutic arsenal and a priority for many biopharma companies.
- Mar 17
- 4 min
Sen-Jam Pharmaceutical proceeds with development of an alcohol hangover prevention
SJP-001 aims to reduce the inflammatory response after alcohol consumption, which should then reduce or prevent a next-day hangover.
- Mar 13
- 5 min
HTL Biotechnology makes strategic investment in GelMedix, for ocular and regenerative therapies
GelMEDIX's most advanced program is focused on developing a sustained release corticosteroid subconjunctival implant.
- Mar 11
- 2 min
The oncology biotech startup DeoBioSciences completes crowdfunding campaign
DeoBioSciences is developing DBX-31, a naturally sourced anticancer protein to address a wide range of advanced stage cancer types.